MedStar Authors catalog › Details for: Triple antithrombotic therapy in patients with atrial fibrillation undergoing Transcatheter Aortic Valve Replacement is associated with higher mortality rate.
Normal view MARC view ISBD view

Triple antithrombotic therapy in patients with atrial fibrillation undergoing Transcatheter Aortic Valve Replacement is associated with higher mortality rate.

by Alraies, M Chadi; Buchanan, Kyle D; Moussa Pasha, Homan; Steinvil, Arie; Rogers, Toby; Koifman, Edward; Gai, Jiaxing; Torguson, Rebecca; Ben-Dor, Itsik; Garcia-Garcia, Hector; Satler, Lowell; Pichard, Augusto D; Waksman, Ron.
Citation: Unpublished 2017/05/01/.Published: 2017Conference: MedStar Health Research Symposium, , North Bethesda, MD., Full author list: Alraies MC; Buchanan KD; Moussa Pasha H; Steinvil A; Rogers T; Koifman E; Gai J; Torguson R; Ben-Dor I; Garcia-Garcia HM; Satler LF; Pichard AD; Waksman R.Local accession number: A2017_014.Institution(s): MedStar Washington Hospital Center | MedStar Health Research Institute | MedStar Heart & Vascular InstituteActivity type: Poster Presentation.

Powered by Koha